In a retrospective analysis of 313 PMBL treated in France and Belgium R-CHOP14 and R-ACVBP had excellent 3 yr OS. Although limited by retrospective nature and likely patent selection these regimens performed better than R-CHOP21. R-ACVBP was more toxic than RCHOP. Patients with high pretreatment TMTV had worse outcomes.
Read the full article here
Audio Interview from the New England Journal of Medicine — Interview with Kevin Schulman on unionization as a response to consolidation and corporatization in health…
Air pollution poses a risk to the respiratory health of individuals with chronic obstructive pulmonary disease (COPD). Long-term and short-term exposu…
This randomized clinical trial assesses the safety and effectiveness of plozasiran, an investigational APOC3-targeted drug, in the reduction of serum triglyceride level in patients with…
This survey study examines preferences and willingness to pay for facility-based vs home-based postacute care among patients and caregivers.
This cross-sectional study uses data from the Youth Risk Behavior surveys to assess the association of state-level recreational marijuana laws and youth marijuana use.
This cohort study examines whether the implementation of legislation is associated with increased bystander cardiopulmonary resuscitation (CPR) and automated external defibrillator use and improved clinical…
This cohort study investigates the risk of uveitis recurrence after COVID-19 vaccination in a cohort of individuals with a history of uveitis.
This case report describes an adult male patient with a severe acneiform eruption on his chest and back.
A lack of information on drug shortages can make it difficult to identify and respond to shortages appropriately, but improving supply chain transparency and federal…
